Effect of androgen deprivation therapy on arterial stiffness and serum lipid profile changes in patients with prostate cancer: a prospective study of initial 6-month follow-up

Increased Cardio-ankle Vascular Index in Hyperlipidemic Patients without Diabetes or Hypertension

(2015) Petr Dobsak et al.   Journal of Atherosclerosis and Thrombosis

The Metabolic Syndrome and its Components in Patients with Prostate Cancer on Androgen Deprivation Therapy

(2015) Juan Morote et al.   JOURNAL OF UROLOGY

Androgen deprivation therapy complications

(2014) Carolyn A Allan et al.   ENDOCRINE-RELATED CANCER

Sarpogrelate Hydrochloride Decreases Cardio-Ankle Vascular Index Accompanied by Increased Serum Lipoprotein Lipase Mass in Type 2 Diabetic Patients

(2014) Daiji Nagayama et al.   International Heart Journal

Development of Nomogram to Non-steroidal Antiandrogen Sequential Alternation in Prostate Cancer for Predictive Model

(2014) Naoto Kamiya et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Clinical outcomes by relative docetaxel dose and dose intensity as chemotherapy for Japanese patients with castration-resistant prostate cancer: a retrospective multi-institutional collaborative study

(2013) Naoto Kamiya et al.   International Journal of Clinical Oncology

Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients

(2013) C. Salvador et al.   UROLOGIA INTERNATIONALIS

Prostate Cancer and Metabolic Syndrome: Is there a link?

(2012) Donovan A. McGrowder et al.   Asian Pacific Journal of Cancer Prevention

Fasting Blood Glucose and Lipid Profile Alterations following Twelve-Month Androgen Deprivation Therapy in Men with Prostate Cancer

(2012) Hasan S. Sağlam et al.   TheScientificWorldJOURNAL

Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer

(2011) Hassanabbas Z. Mohamedali et al.   CUAJ-Canadian Urological Association Journal

The Effects of Androgen Deprivation Therapy on Lipid Metabolism and Body Composition in Japanese Patients with Prostate Cancer

(2011) K. Torimoto et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Contradictory Effects of β1- and α1- Aderenergic Receptor Blockers on Cardio-Ankle Vascular Stiffness Index (CAVI)

(2011) Kohji Shirai et al.   Journal of Atherosclerosis and Thrombosis

Cardio-Ankle Vascular Index (CAVI) as a Novel Indicator of Arterial Stiffness: Theory, Evidence and Perspectives

(2011) Kohji Shirai et al.   Journal of Atherosclerosis and Thrombosis

Usefulness of LDL-C-Related Parameters to Predict Cardiovascular Risk and Effect of Pravastatin in Mild-to-Moderate Hypercholesterolemia

(2011) Kyoichi Mizuno et al.   Journal of Atherosclerosis and Thrombosis

Association between serum sex hormone levels and prostate cancer: effect of prostate cancer on serum testosterone levels

(2009) Takashi Imamoto et al.   Future Oncology

Effect of Androgen Suppression Compared With Androgen Receptor Blockade on Arterial Stiffness in Men With Prostate Cancer

(2009) F. Dockery et al.   JOURNAL OF ANDROLOGY

Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer

(2009) Philip J. Saylor et al.   JOURNAL OF UROLOGY

Current topics and perspectives relating to hormone therapy for prostate cancer

(2008) Hiroyoshi Suzuki et al.   International Journal of Clinical Oncology

Androgen Deprivation Therapy in Prostate Cancer and Metabolic Risk for Atherosclerosis

(2008) Sadeka Shahani et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III Study

(2008) Matthew R. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY